<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_BostonU_Data"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:BostonU/Data">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:BostonU/Data&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:BostonU/Data&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:BostonU/Data&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:BostonU/Data" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:BostonU/Data</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><UL id="nav"><LI><A href="https://2014.igem.org/Team:BostonU/Team">TEAM</A></LI><LI><A href="">PROJECT</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Chimera">Overview</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Encoder">Priority Encoder</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/MoClo">MoClo Assembly Method</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Backbones">Low Copy Backbones</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">Tandem Promoters</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/FusionProteins">Fusion Proteins</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Repressors">Repressor Proteins</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Multiplexing">Multiplexing</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Software">BioDesign Automation Tools</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Future">Future Work</A></LI></UL><LI><A href="">ACHIEVEMENTS</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Data">Data Collected</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Parts">Parts Submitted</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Workflow">Chimera Workflow</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/ChimeraExample">Chimera Example</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Medals">Medal Fulfillment</A></LI><LI><A href="">NOTEBOOK</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Training">Training</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Protocols">Protocols</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/BackbonesNotebook">Backbones</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/TandemPromoters">Tandem Promoters and Repressors</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/FusionProteinsNotebook">Fusion Proteins</A></LI><LI><A href="">CONSIDERATIONS</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Collaborations">Collaborations</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Measurement">Measurement Track</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Safety">Safety</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/NEGEM">NEGEM</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/HumanPractices">Policy and Practices</A></LI><LI><A href="https://2014.igem.org/Team:BostonU/Acknowledgements">ACKNOWLEDGEMENTS</A></LI><DIV class="pagescontent"><PAGEHEADER>Data Collected</PAGEHEADER><MAINCONTENT><P>As a measurement team, we completed the Interlab Study. For more information about our Interlab Study results, please refer to our <A href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</A> page.

</P><H2><LEFT>Flow Cytometry Data</LEFT></H2><H7><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2"><H3>pTet-pBad RFP Characterization with atc and arabinose</H3></TD></TR><TR><TD scope="col">For the first tandem promoter flow cytometry experiment, we tested pBad-pTet-BCD2-E1010m-B0015 and pTet-pBad-BCD2-E1010m-B0015. We planned on inducing each promoter separately with it's corresponding small molecule (either arabinose or atc) and also planned on inducing both together. We followed the <A href="https://2014.igem.org/Team:BostonU/Protocols">flow cytometry workflow</A>. By growing the constructs in different concentrations of media, we hoped to see RFP fluorescence increase as the small molecule concentration increased. For each concentration, we also had a negative. We also ran controls including: J04B2RM (RFP Positive), J04B2GM (GFP Positive), COXGR, COXRG, and DH5alpha. For an explanation of how we chose our controls, please refer to our <A href="https://2014.igem.org/Team:BostonU/Software">Software Tools</A> page.The pTet-pBad graph turned out the way we expected and showed the anticipated function. For the 5,000 and 10,000 ng/ul atc concentrations (for both graphs), the cells died because of the high concentrations. This is why the graph dropped rapidly.  </TD></TR><TR><TD scope="col"><CAPT>Figure 1: Flow Cytometry graph for pTet-pBad level 1 construct with RFP for three conditions: atc (red), arabinose (blue), atc and arabinose (purple)</CAPT></TD></TR></TBODY></TABLE><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2"><H3>pBad-pTet RFP Characterization with atc and arabinose</H3></TD></TR><TR><TD scope="col">For the pBad-pTet construct, we used the same controls as mentioned above. According to literature, the pTet-pBad construct has not previously functioned as suspected. This was possibly due to position-dependence interference [1]. Conversely, our flow cytometer data showed that pTet-pBad had a greater range of fluorescence than pBad-pTet. We will need to do further investigating to find out why this was the case. Unlike results in the literature, our pTet-pBad construct worked well, but the pBad-pTet didn't show anticipated function. We are predicting that the arabinose concentrations were too low for this experiment and the atc concentrations were too high. We are planning to run another flow experiment before the jamboree with new small molecule concentrations. We hope that this will improve function (fluorescence expression) and reduce the error bars. </TD></TR><TR><TD scope="col"><CAPT>Figure 2: Flow Cytometry graph for pBad-pTet level 1 construct with RFP for three conditions: atc (red), arabinose (blue), atc and arabinose (purple) </CAPT></TD></TR></TBODY></TABLE><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2"><H3>Testing of p15A origin of replication</H3></TD></TR><TR><TD scope="col">Flow cytometry testing of the p15A origin was performed with the <A href="https://2014.igem.org/Team:BostonU/Protocols">flow cytometry workflow</A> using <A href="https://static.igem.org/mediawiki/2014/1/18/Flow108controls_BU14.png">constitutively-expressed GFP and RFP controls</A>. The similarities in fluorescence between the transcriptional units with the pMB1 and p15A origins were not expected, as only approximately 10-25 plasmids should be present per cell with the p15A origin in contrast with the pMB1 origin, which allows for over 100 plasmids per cell. This result may be due to the use of strong promoters and RBSs in the experiment, which may have caused overexpression of the fluorescent reporter and overshadowed any change brought about by changing the origin of replication.
</TD></TR><TR><TD scope="col"><CAPT>Figure 3: Flow Cytometry graph for the p15A and pMB1 origins of replication with constitutively expressed GFP and RFP. </CAPT></TD></TR><TR><TD scope="col" colspan="2">Alternatively, these results may be due to a deviation in the protocol necessitated by poor cell growth - on day 2 of the flow cytometry workflow, the 8-hour liquid cultures were grown in contaminated deep-well plates that resulted in no cell growth. The transformed colonies had to be re-picked and grown after this delay, which may have affected the folding and expression of the fluorescent proteins. This experiment will be repeated with freshly-transformed cells and a weaker promoter and RBS, and its results will be presented at the Jamboree.</TD></TR></TBODY></TABLE><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2"><H3>Collaboration with Team WPI-Worcester</H3></TD></TR><TR><TD scope="col">This data is a result of our collaboration with Team WPI-Worcester. They gave us two copies of the same construct, in different antibiotic resistant backbones. This construct expresses <A href="http://parts.igem.org/Part:BBa_K1423005"> BclA-YFP </A>, a cell surface targeted protein that expresses YFP on the cell surface. Our intention was to compare BclA expression with expression of our internal YFP control (J23104+BCD2+YFP+B0015). As evident from Figure 4, the Internal YFP has an expression of over 2 * 10^4 MEFLs, while none of the BclA constructs have expression more than 10^4 MEFLs. This data is, however, inconclusive as the internal YFP is in a Kanamycin resistant backbone and as we have shown, different backbones can lead to greatly varied data.
</TD></TR><TR><TD scope="col"><CAPT>Figure 4: Expression of BclA-YFP constructs as compared to Internal YFP expression</CAPT></TD></TR></TBODY></TABLE><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2">Below are the micrographs team WPI-Worcester took for us. They used confocal microscopy to view cells containing tandem promoter + RFP testing constructs. These constructs were also tested using flow cytometry as described above. For details on experimental setup, click <A href="https://2014.igem.org/Team:BostonU/Collaborations">here</A>. Both constructs expressed RFP for 100mM arabinose (on state) and did not express RFP for 1mM. While we did not test 100mM in our previous flow experiment, the confocal microscopy shows the same trend that we would expect for arabinose. For atc, the confocal experiment differed from our flow cytometry results because we expected an on state for 1000 ng/mL. This will require further investigation and a repeat experiment. It is possible that we mixed up the media that we gave to WPI. Likewise, the presence of GFP in some of the cells suggests we may have gave them a mixed culture since we didn't see GFP for the same constructs when we ran flow cytometry analysis.
</TD></TR><TR><TD scope="col"><CAPT>Figure 5: Micrographs showing the expression of RFP and GFP at different small molecule concentrations for pTet+pBAD+ RFP</CAPT></TD><TD scope="col"><CAPT>Figure 6: Micrographs showing the expression of RFP and GFP at different small molecule concentrations for pBAD+pTet +RFP</CAPT></TD></TR></TBODY></TABLE><TABLE width="100%" border="0" cellspacing="15" cellpadding="0"><TBODY><TR><TD scope="col" colspan="2"><H3>Fusion Protein GFP Expression</H3></TD></TR><TR><TD scope="col">Though we were unable to successfully clone the testing constructs listed <A href="https://2014.igem.org/Team:BostonU/FusionProteins"> here</A>, we tested the single transcriptional units with GFP and YFP fusion proteins to check whether there was any protein expression at all. It was hypothesized that because the two heavy gene sequences in a fusion protein are very close to each other, GFP expression wouldn't be as high as it would in a single GFP control. The hypothesis was accepted based on the results on Figure 7. However, it should be noted that the fluorescence for both <I>tetR+GFP</I> and  <I>araC+GFP</I> is not greatly different from that for just GFP. This cannot be used to conclude whether the fusion proteins affect regulator function. For that, we will need to test the testing constructs designed. We should be able to present that data at the Jamboree.
</TD></TR><TR><TD scope="col"><CAPT>Figure 7: Flow Cytometry results comparing GFP expression of fused proteins and that for the single GFP control.</CAPT></TD></TR></TBODY></TABLE><H2><LEFT>Eugene</LEFT></H2>
Here are the Eugene files for the tandem promoters, tandem promoter test devices, fusion proteins, and the Priority Encoder.<A href="https://static.igem.org/mediawiki/2014/8/89/BU14Tandem_promoters_only_FullEugene.txt">Tandem promoter basic parts</A><A href="https://static.igem.org/mediawiki/2014/2/29/Tandem-promoters-TU-Testing.txt">Tandem promoter test devices</A><A href="https://static.igem.org/mediawiki/2014/1/13/BU14_Fusion_Proteins_only.txt">Fusion protein basic parts</A><A href="https://static.igem.org/mediawiki/2014/5/5a/Priority_Encoder_full_Eugene.txt">Priority encoder</A><H2><LEFT>Raven</LEFT></H2>
Here is the Raven input files for tandem promoters, tandem promoter test devices, and the Priority Encoder.<A href="https://static.igem.org/mediawiki/parts/9/9a/Basic_tandem_raven.txt">Tandem Promoters</A><A href="https://static.igem.org/mediawiki/parts/2/23/Tandem_promoters_TU_testing.txt">Tandem Promoter Test Devices</A><A href="https://static.igem.org/mediawiki/parts/d/d1/Priority_encoder_raven.txt">Priority Encoder</A><H2><LEFT>SBOL</LEFT></H2>
Here is the SBOL file for the Priority Encoder.<A href="https://static.igem.org/mediawiki/parts/8/8d/Priority_encoder_sbol.txt">Priority Encoder</A><H2>Primer Designs</H2><H3>Primer Design for Tandem Promoters and Repressor Genes</H3><H7><CENTER><TABLE id="devices" cellpadding="5" style="border:1px solid black; border-collapse:collapse"><TBODY><TR><TH style="border:1px solid black"><FONT color="#B22222"> Device Name </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Forward Primer </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Sequence 5' to 3'  </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Reverse Primer </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Sequence 5' to 3'  </FONT></TH></TR><TR><TD style="border:1px solid black;"> BetI_CD </TD><TD style="border:1px solid black;"> BetI_For_C </TD><TD style="border:1px solid black;"> ATGAAGACGTAATGGTGCCGAAACTGGGTATGCAGAGC </TD><TD style="border:1px solid black;"> BetI_Rev_D </TD><TD style="border:1px solid black;"> ACGAAGACCTACCTTTAATCGGTCGGCAGATGCTGGGT </TD></TR><TR><TD style="border:1px solid black;"> PhlF_CD </TD><TD style="border:1px solid black;"> PhlF_For_C </TD><TD style="border:1px solid black;"> ATGAAGACGTAATGATGGCACGTACCCCGAGCCGTAGC </TD><TD style="border:1px solid black;"> PhlF_Rev_D </TD><TD style="border:1px solid black;"> ACGAAGACCTACCTTTAACGCTGTGTACCCGGACAAAC </TD></TR><TR><TD style="border:1px solid black;"> BM3R1_CD </TD><TD style="border:1px solid black;"> BM3R1_For_C </TD><TD style="border:1px solid black;"> ATGAAGACGTAATGATGGAAAGCACCCCGACCAAACAG </TD><TD style="border:1px solid black;"> BM3R1_Rev_D </TD><TD style="border:1px solid black;"> ACGAAGACCTACCTTTAGCTCTGACGGCTCAGTGCTGC </TD></TR><TR><TD style="border:1px solid black;"> LmrA_CD </TD><TD style="border:1px solid black;"> LmrA_For_C </TD><TD style="border:1px solid black;"> ATGAAGACGTAATGATGAGCTATGGTGATAGCCGTGAA </TD><TD style="border:1px solid black;"> LmrA_Rev_D </TD><TD style="border:1px solid black;"> ACGAAGACCTACCTTTAACGTTTCAGCAGATCCGGAAT </TD></TR><TR><TD style="border:1px solid black;"> SrpR_CD </TD><TD style="border:1px solid black;"> SrpR_For_C </TD><TD style="border:1px solid black;"> ATGAAGACGTAATGATGGCACGTAAAACCGCAGCAGAA </TD><TD style="border:1px solid black;"> SrpR_Rev_D </TD><TD style="border:1px solid black;"> ACGAAGACCTACCTTTATTCGAAGGATTTCACCTGTTT </TD></TR><TR><TD style="border:1px solid black;"> pTet_AK </TD><TD style="border:1px solid black;"> pTet_For_A  </TD><TD style="border:1px solid black;"> ATGAAGACGTGGAGTCCCTATCAGTGATAGAGATTGAC </TD><TD style="border:1px solid black;"> pTet_Rev_K </TD><TD style="border:1px solid black;"> ACGAAGACCTGCATTTCGGTCAGTGCGTCCTGCTGATG </TD></TR><TR><TD style="border:1px solid black;"> pTet_KB </TD><TD style="border:1px solid black;"> pTet_For_K </TD><TD style="border:1px solid black;"> ATGAAGACGTATGCTCCCTATCAGTGATAGAGATTGAC </TD><TD style="border:1px solid black;"> pTet_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTATTCGGTCAGTGCGTCCTGCTGATG </TD></TR><TR><TD style="border:1px solid black;"> pBad_AK </TD><TD style="border:1px solid black;"> pBad_For_A </TD><TD style="border:1px solid black;"> ATGAAGACGTGGAGAAGAAACCAATTGTCCATATTGCA </TD><TD style="border:1px solid black;"> pBad_Rev_K </TD><TD style="border:1px solid black;"> ACGAAGACCTGCATTATGGAGAAACAGTAGAGAGTTGC </TD></TR><TR><TD style="border:1px solid black;"> pBad_KB </TD><TD style="border:1px solid black;"> pBad_For_K  </TD><TD style="border:1px solid black;"> ATGAAGACGTATGCAAGAAACCAATTGTCCATATTGCA </TD><TD style="border:1px solid black;"> pBad_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTATATGGAGAAACAGTAGAGAGTTGC </TD></TR><TR><TD style="border:1px solid black;"> pSrpR_KB </TD><TD style="border:1px solid black;"> pSrpR_For_K  </TD><TD style="border:1px solid black;"> ATGAAGACGTATGCTTCGTTACCAATTGACAGCTAGCT </TD><TD style="border:1px solid black;"> pSrpR_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTAGTTTACAAACAAACAAGCATGTAT </TD></TR><TR><TD style="border:1px solid black;"> pLmrA_FK </TD><TD style="border:1px solid black;"> pLmrA_For_F  </TD><TD style="border:1px solid black;"> ATGAAGACGTCGCTTTCGTTACCAATTGACAACTGGTG </TD><TD style="border:1px solid black;"> pLmrA_Rev_K </TD><TD style="border:1px solid black;"> ACGAAGACCTGCATAAATATAGTGACTGGTCTATTATC </TD></TR><TR><TD style="border:1px solid black;"> pBetI_EB </TD><TD style="border:1px solid black;"> pBet_For_E  </TD><TD style="border:1px solid black;"> ATGAAGACGTGCTTTTCATGGATTCGTTACCAATTGAC </TD><TD style="border:1px solid black;"> pBetI_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTAGCTAGCATTATATTGAACGTCCAA </TD></TR><TR><TD style="border:1px solid black;"> pPhlF_GB </TD><TD style="border:1px solid black;"> pPhlF_For_G  </TD><TD style="border:1px solid black;"> ATGAAGACGTTGCCTTCGTTACCAATTGACATGATACG </TD><TD style="border:1px solid black;"> pPhlF_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTAACCTTAACGATACGGTACGTTTCG </TD></TR><TR><TD style="border:1px solid black;"> pBM3R1_FB </TD><TD style="border:1px solid black;"> pBM3R1_For_F  </TD><TD style="border:1px solid black;"> ATGAAGACGTCGCTTTCGTTACCAATTGACGGAATGAA </TD><TD style="border:1px solid black;"> pBM3R1_Rev_B </TD><TD style="border:1px solid black;"> ACGAAGACCTAGTAGCTAGCATTATCGGAATGAACGTT </TD></TR></TBODY></TABLE></CENTER><H3><LEFT>Primer Design for Fusion Proteins</LEFT></H3><H7><CENTER><TABLE id="devices" style="border:1px solid black; border-collapse:collapse"><TBODY><TR><TH style="border:1px solid black"><FONT color="#B22222"> Device Name </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Primer </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Sequence 5' to 3'  </FONT></TH></TR><TR><TD style="border:1px solid black;"> C0080_CI </TD><TD style="border:1px solid black;"> C0080_Rev_I </TD><TD style="border:1px solid black;"> ACGAAGACCTTAGACAACTTGACGGCTACATCATTCAC </TD></TR><TR><TD style="border:1px solid black;"> C0040_CI </TD><TD style="border:1px solid black;"> C0040_Rev_I </TD><TD style="border:1px solid black;"> ACGAAGACCTTAGACAACTTGACGGCTACATCATTCAC  </TD></TR><TR><TD style="border:1px solid black;"> E0040m_ID </TD><TD style="border:1px solid black;"> E0040m_For_I </TD><TD style="border:1px solid black;"> ATGAAGACGTTCTAGAATGCGTAAAGGAGAAGAACTTTTC  </TD></TR><TR><TD style="border:1px solid black;"> E0030_ID </TD><TD style="border:1px solid black;"> E0030_For_I </TD><TD style="border:1px solid black;"> ATGAAGACGTTCTAGAATGGTGAGCAAGGGCGAGGAGCTG  </TD></TR></TBODY></TABLE></CENTER><H3><LEFT>Primer design for Origins of Replication</LEFT></H3><H7><CENTER><TABLE id="devices" cellpadding="5" style="border:1px solid black; border-collapse:collapse"><TBODY><TR><TH style="border:1px solid black"><FONT color="#B22222"> Device Name </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Forward Primer </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Sequence 5' to 3'  </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Reverse Primer </FONT></TH><TH style="border:1px solid black"><FONT color="#B22222"> Sequence 5' to 3'  </FONT></TH></TR><TR><TD style="border:1px solid black;"> DVL1_AE </TD><TD style="border:1px solid black;"> DVL1_AE_FWD </TD><TD style="border:1px solid black;"> ATCGATCAATTGGATTATCAAAAAGGATCTTCACCT </TD><TD style="border:1px solid black;"> DVL1_AE_REV </TD><TD style="border:1px solid black;"> ATCGATGGCGCGCCTTTTTACGGTTCCTGGCCTTTTGC </TD></TR><TR><TD style="border:1px solid black;"> DVL2_AF </TD><TD style="border:1px solid black;"> DVL2_AF_FWD </TD><TD style="border:1px solid black;"> ATCGATCAATTGGATTATCAAAAAGGATCTTCACCT </TD><TD style="border:1px solid black;"> DVL2_AF_REV </TD><TD style="border:1px solid black;"> ATCGATGGCGCGCCTTTTTACGGTTCCTGGCCTTTTGC </TD></TR><TR><TD style="border:1px solid black;"> ColE1 </TD><TD style="border:1px solid black;"> ColE1_FWD </TD><TD style="border:1px solid black;"> ATCGATCAATTGGGCCGCGTTGCTGGCGTTTTTCCA </TD><TD style="border:1px solid black;"> ColE1_REV </TD><TD style="border:1px solid black;"> ATCGATGGCGCGCCTCATGACCAAAATCCCTTAACGTG </TD></TR><TR><TD style="border:1px solid black;"> p15A </TD><TD style="border:1px solid black;"> p15A_FWD </TD><TD style="border:1px solid black;"> ATCGATCAATTGAAATATTTTATCTGATTAATAAGA </TD><TD style="border:1px solid black;"> p15A_REV </TD><TD style="border:1px solid black;"> ATCGATGGCGCGCCTAGCGGAGTGTATACTGGCTTACT </TD></TR><TR><TD style="border:1px solid black;"> pSC101 </TD><TD style="border:1px solid black;"> pSC101_FWD </TD><TD style="border:1px solid black;"> ATCGATCAATTGTCAGATCCTTCCGTATTTAGCCAG </TD><TD style="border:1px solid black;"> pSC101_REV </TD><TD style="border:1px solid black;"> ATCGATGGCGCGCCATGTCTGAATTAGTTGTTTTCAAA </TD></TR></TBODY></TABLE></CENTER><H3>References</H3>
[1] A. Tamsir, J. Tabor, C. Voigt (2011). “Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’.” Nature 469: 212-215

</H7></H7></H7></H7></MAINCONTENT></DIV><DIV class="sponsors" align="center"><HEADER1>Our Sponsors</HEADER1></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:BostonU/Data">http://2014.igem.org/Team:BostonU/Data</A>&quot;</DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:BostonU/Data" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:BostonU/Data" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:BostonU/Data&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:BostonU/Data&amp;oldid=334866" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></BODY></HTML>